JG
ADMA icon

Jefferies Group’s ADMA Biologics ADMA Stock Holding History

Jefferies Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500,000
Closed -$2.23M – 2513
2019
Q3 		$2.23M Sell
500,000
-265,000
-35% -$1.11M 0.02% 1008
2019
Q2 		$2.96M Buy
+765,000
New +$3.38M 0.02% 726
2018
Q2 		– Sell
-18,900
Closed -$87K – 2272
2018
Q1 		$87K Buy
+18,900
New +$75.1K ﹤0.01% 2086

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $131M AUM 101.21% 1-Year Est. Return

Jefferies Group's ADMA Position: Q4 2019 in Review

Jefferies Group sold out of ADMA Biologics (ADMA) in Q4 2019, closing a stake of 500,000 shares — an estimated $2.23M sold.

Jefferies Group first reported a position in ADMA in Q1 2018 and held it in 3 quarters. The position peaked at $2.96M in Q2 2019. 74 funds tracked by Wall St. Rank hold ADMA as of Q4 2019.

  • Jefferies Group reported no remaining ADMA Biologics position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 500,000 ADMA Biologics shares in Q4 2019, an estimated $2.23M.
  • Jefferies Group first reported a position in ADMA Biologics in Q1 2018 and held it in 3 quarters.
  • Jefferies Group's ADMA Biologics position peaked at $2.96M in Q2 2019.
  • 74 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.